 The purpose of this study is to examine the pharmacokinetics PK, safety and tolerability of 3 intranasal IN doses 0.5, 1.0 and 2.0 mg of Granisetron Hydrochloride Nasal Sprays GNS as compared to Granisetron IV Injection and Granisetron Tablet in healthy Volunteers. 